ESC Premium Access

NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?

Congress Presentation

About the speaker

Professor Julinda Mehilli

Hospital Landshut-Achdorf, Landshut (Germany)
30 presentations
14 followers

2 more presentations in this session

What is the latest randomized evidence in TAVI field.

Speaker: Professor A. Baumbach (London, GB)

Thumbnail

Is durability still an issue?

Speaker: Professor E. Durand (Rouen, FR)

Thumbnail

Access the full session

Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

Speakers: Professor J. Mehilli, Professor A. Baumbach, Professor E. Durand
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb